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Abstract
Background:  Adipose derived- and bone marrow-derived murine mesenchymal stem cells
(mMSCs) may be used to study stem cell properties in an in vivo setting for the purposes of
evaluating therapeutic strategies that may have clinical applications in the future. If these cells are
to be used for transplantation, the question arises of how to track the administered cells. One
solution to this problem is to transplant cells with an easily identifiable genetic marker such as
enhanced green fluorescent protein (eGFP). This protein is fluorescent and therefore does not
require a chemical substrate for identification and can be visualized in living cells. This study seeks
to characterize and compare adipose derived- and bone marrow-derived stem cells from C57Bl/6
mice and eGFP transgenic C57Bl/6 mice.
Results: The expression of eGFP does not appear to affect the ability to differentiate along
adipogenic or osteogenic lineages; however it appears that the tissue of origin can influence
differentiation capabilities. The presence of eGFP had no effect on cell surface marker expression,
and mMSCs derived from both bone marrow and adipose tissue had similar surface marker profiles.
There were no significant differences between transgenic and non-transgenic mMSCs.
Conclusion: Murine adipose derived and bone marrow derived mesenchymal stem cells from
non-transgenic and eGFP transgenic C57Bl/6 mice have very similar characterization profiles. The
availability of mesenchymal stem cells stably expressing a genetic reporter has important
applications for the advancement of stem cell research.
Background
Mesenchymal stem cells can be broadly defined as a pop-
ulation of cells that have the ability to self-renew, adhere
to plastic, and to differentiate into one or more special-
ized cell types [1-3]. Tissue specific stem cells, such as
mesenchymal stem cells (MSCs) derived from bone mar-
row or adipose tissue, were initially thought to have a dif-
ferentiation capacity limited to the tissue of origin.
However, recent studies have shown that these cells may
have the ability to differentiate into cells of mesodermal,
endodermal, and ectodermal origins [4-8]. The term
"mesenchymal stem cell" most often refers to stem cells
derived from the stromal fraction of bone marrow, but
can also be applied to stem cells derived from adipose tis-
sue. Adipose tissue is also derived from the mesenchyme
and contains a supportive stroma that is easily isolated
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[4,9]. Both adipose derived stem cells (ASCs) and bone
marrow derived stem cells (BMSCs) can be easily har-
vested in significant numbers and exhibit stable growth
and proliferation in culture.
MSCs have garnered increasing amounts of attention for
their potential use in cell-based therapies and in regener-
ative medicine because of several attractive features: (1)
they are easily isolated by bone marrow aspiration or lipo-
suction under local anesthesia; (2) they can be extensively
expanded in culture without loss of differentiation poten-
tial; (3) MSCs can differentiate into multiple cell types;
(4) MSCs have the ability to seek out sites of tissue injury
and repair the tissue by differentiating to replace injured
cells or by creating an environment favorable for the
repair of damaged tissue by endogenous cells [10]. The
utilization of MSCs derived from the adipose tissue or
bone marrow of mice is appealing for use in extensive
studies in the field of adult stem cell research due to the
low cost of maintaining mice. These murine MSCs
(mMSCs) may be used to study stem cell properties in an
in vivo setting for the purposes of evaluating therapeutic
strategies that may have clinical applications in the future.
Whenever cells are to be used in a transplantation sce-
nario, the question of how to track the engraftment, per-
sistence, and differentiation of the administered cells
arises. Tracking the cells should help determine whether a
tissue is repaired by the transplanted stem cells, by activa-
tion of host stem cells, or by host cells recruited by the
transplanted stem cells to the site of injury.
Several reporter gene or tracking strategies are currently
being developed to assist investigators with experimental
stem cell therapies. Cells can be transfected or transduced
with vectors carrying a fluorescent transgene, but these
methods are limited by the efficiency of gene transfer and
retention [11-13]. Other reporter genes may encode
enzymes such as β-galactosidase (lacZ), chloramphenicol
acetyltransferase, and firefly luciferase. These enzymes
require the addition of substrates to visualize labeled cells,
which may lead to background staining if endogenous
enzymes can also process the added substrate [14-16].
Fluorescent DNA binding dyes such as bis-benzimide are
also available [17], but are also limited by binding effi-
ciencies and background fluorescence from DNA released
from dead cells. Transplanting cells harvested from a male
donor into a female host and searching for the Y-chromo-
some is also a simple and effective strategy for tracking
cells, but this technique cannot be utilized in living cells.
One solution to this problem is to transplant cells with an
easily detectable or identifiable genetic reporter element.
An ideal reporter gene would (1) cause no adverse effects
to the stem cells or host development; (2) be ubiquitously
expressed in all transplanted cells; (3) be precisely local-
ized to transplanted cells; (4) be reliably detected in living
cells, tissue mounts, and fixed and paraffin-embedded
sections; and (5) be compatible with visualization of
other markers [15]. For these purposes, an ideal approach
is to harvest stem cells from a transgenic mouse strain
expressing a transgene marker. These cells can be trans-
planted into non-transgenic mice without the complica-
tion of background staining.
One such transgene marker is enhanced green fluorescent
protein (eGFP). eGFP is an excellent reporter because it
can be visualized in living cells in culture and has already
been useful in monitoring gene expression, protein-pro-
tein interactions, and trafficking and localization in vivo
[15,18-21]. eGFP-expressing transgenic mice are readily
available and are a possible source for murine ASCs
(mASCs) and murine BMSCs (mBMSCs) which constitu-
tively express eGFP [21]. These mice are uniformly green
with the exceptions of hair and red blood cells [12].
The efficiency of establishing stable cell lines with an inte-
grated eGFP gene is normally low, therefore cells from
eGFP transgenic mice may prove more useful and easier to
culture [22]. However, employing eGFP as a means of
tracking cells has a couple drawbacks. One limitation is
that eGFP/GFP is thought to induce cell death [12].
Intense excitation of the protein in vitro for extended peri-
ods of time can generate toxic free radicals, and the pres-
ence of GFP may also lead to increased DNA methylation
[22,23]. eGFP was also designed to be expressed in the
cytosol of a cell, which could lead to toxic effects if present
in high concentrations. In spite of these potential obsta-
cles, cell lines from transgenic mice often look normal and
healthy even though they express significant amounts of
eGFP [14].
This study seeks to characterize and compare four differ-
ent groups of mMSCs consisting of mASCs and mBMSCs
derived from C57Bl/6 mice and mASCs and mBMSCs
derived from eGFP transgenic C57Bl/6 mice (GFPTgASCs
and GFPTgBMSCs). Characteristics such as differentiation
potential, colony forming unit capabilities, cell surface
marker profiles, and growth kinetics of these four groups
of cells were evaluated in order to give future investigators
a clearer understanding of the properties of eGFP trans-
genic mMSCs (GFPTgMSCs). Mesenchymal stem cells
derived from eGFP transgenic mice may prove useful in
future testing and development of stem cell therapies and
regenerative medicine applications because of their inher-
ent stem cell properties and constitutive expression of the
fluorescent protein eGFP.BMC Cell Biology 2009, 10:3 http://www.biomedcentral.com/1471-2121/10/3
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Results
Morphology of Transgenic mMSCs
The morphology of transgenic mMSCs is consistent with
that of normal mMSCs in that they are fibroblastic in
appearance. mBMSCs and GFPTgBMSCs seem to be more
spindle-shaped than mASCs or GFPTgASCs, thus individ-
ual mASCs and GFPTgASCs require more surface area on
the culture dish due to their larger and more flattened
shape. GFPTgMSCs fluoresce when examined through a
FITC filter (Figure 1), and remained fluorescent and main-
tained morphology through passage 10 (data not shown).
The mMSCs were not cultured past passage 10 for this
study.
Differentiation Assays
When cultured mMSCs (mBMSCs, mASCs, GFPTgASCs,
and GFPTgBMSCs) were exposed to an osteogenic induc-
tion medium, they aggregated and formed calcium depos-
its after 2 weeks. An alizarin red stain for precipitated
calcium salt was performed on differentiated cells. The
mMSCs (Passage 9 or lower) readily underwent osteo-
genic differentiation into mineralizing cells, and the trans-
genic mMSCs and normal mMSCs differentiated in a
similar manner (Figure 2A). However, quantitation of the
levels of differentiation in these cell populations indicated
that the mBMSCs (Optical Density (OD) ratio = 7.2 +/-
3.8) and GFPTgBMSCs (OD ratio = 9.7 +/- 6.6) appeared
to differentiate into mineralizing cells to a greater degree
than the mASCs (OD ratio = 1.1 +/- 0.6) and GFPTgASCs
(OD ratio = 1.45 +/- 0.4) (p < 0.05) (Figure 3A). Graphs
represent the ratio of normalized OD of differentiated
cells and normalized OD of control cells.
The ability to differentiate into adipocytes in response to
2 weeks of culture in adipogenic induction media was
similar between the mMSCs and transgenic mMSCs (Pas-
sage 9 or lower). The mASCs (OD ratio = 13.3 +/- 8.1) and
GFPTgASCs (OD ratio = 2.9 +/- 2.6) differentiated along
adipogenic lineages and had slightly higher levels of lipid
accumulation when stained with Oil Red O than mBMSCs
(OD ratio = 1.6 +/- 0.6) or GFPTgBMSCs (OD ratio = 1.6
+/- 0.9), though this difference was not statistically signif-
icant (p > 0.05) (Figure 3B). Graphs represent the ratio of
normalized OD of differentiated cells and normalized OD
of control cells.
GFPTgASCs and GFPTgBMSCs retain their ability to fluo-
resce when examined through a FITC filter even after
undergoing adipogenic (Figure 2B) or osteogenic differen-
tiation assays. The fluorescence after osteogenic differenti-
ation is not pictured because osteogenic differentiation is
not easily illustrated without an Alizarin Red stain, which
Morphology and fluorescence of GFPTgASCs and GFPTgBMSCs Figure 1
Morphology and fluorescence of GFPTgASCs and GFPTgBMSCs. Top: ASCs derived from eGFP+ transgenic C57Bl/6 
mice (P4), Bottom: BMSCs derived from eGFP+ transgenic C57Bl/6 mice (P3). 20× magnification.
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A. Differentiation of mMSCs and GFPTgMSCs along mesodermal lineages Figure 2
A. Differentiation of mMSCs and GFPTgMSCs along mesodermal lineages. Cells were incubated in CEM and then 
transferred to adipogenic or osteogenic media for 14 days. All cells were passage 9 or lower. Cells which formed lipid vacuoles 
were stained with Oil Red-O while mineralization in osteogenic-differentiated cells was revealed with Alizarin Red staining.B. 
GFPTgMSCs retain fluorescence after differentiation. MSCs derived from eGFP+ transgenic C57Bl/6 mice (P6) retain fluores-
cence even after stimulated to undergo adipogenic differentiation. 20× magnification.
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Quantitative differentiation of mMSCs and GFPTgMSCs along osteogenic and adipogenic lineages Figure 3
Quantitative differentiation of mMSCs and GFPTgMSCs along osteogenic and adipogenic lineages. A. Cells 
were incubated in CEM and then transferred to osteogenic media for 14 days. The cells were then stained with Alizarin Red 
and de-stained with 10% cetylpyridinium chloride. Optical density (OD) was measured at 560 nm and normalized to protein 
content. Graphs represent the ratio of normalized OD of differentiated cells and normalized OD of control cells. B. Cells were 
incubated in CEM and then transferred to adipogenic media for 14 days. The cells were then stained with Oil Red O and de-
stained with isopropanol. OD was measured at 520 nm and normalized to protein content. Graphs represent the ratio of nor-
malized OD of differentiated cells and normalized OD of control cells.
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consequently quenches the fluorescence due to the low
pH of the stain.
A chondrogenic differentiation assay was performed with
all mMSCs (data not shown), and all cell types formed
stable pellets. However, the mMSCs produced little prote-
oglycans in response to chondrogenic differentiation
media. The inability of mMSCs from C57Bl/6 and other
strains of mice to undergo efficient chondrogenesis has
been noted previously [24] and may be attributed to the
lack of murine specific cytokines.
FACS analysis
Flow cytometric analysis of cell surface markers revealed
that all of the mMSCs and GFPTgMSCs were virtually
identical in their patterns of expression (Figure 4A). Cells
were tested for expression of markers such as CD106
(VCAM-1), Sca-1 (stem cell antigen-1; Ly6A/E), CD34
(mucosialin), CD11b (Mac-1α; Integrin alpha M), and
CD45 (leukocyte common antigen; Ly-5). All cells exhib-
ited very low expression of epitopes generally associated
with hematopoietic cells such as CD34 (5.4% +/- 5.0%),
CD11b (0.2% +/- 0.3%), and CD45 (1.3% +/- 0.8%) [25].
Approximately half of the cells expressed CD106 (48.3%
+/- 9.2%), which is a marker generally associated with
mesenchymal stem cells [25]. Most cells expressed Sca-1
(79.4% +/- 8.3%), which is a marker associated with
MSCs, but also with hematopoietic and endothelial pro-
genitors [11,25,26] (Figure 4B).
Growth Kinetics
All mMSCs and GFPTgMSCs were plated at a density of
100 cells/cm2 in 56.7 cm2 plates and cultured for 12 days.
Fold increase in density was analyzed every 3 days
throughout the culture and calculated by comparing the
density at each time point to the original plating density
of 100 cells/cm2. As illustrated in Figure 5, the four groups
of mMSCs varied greatly from one another in their growth
rates. mASCs had a 46-fold increase (+/-24.6) in cell
number while GFPTgASCs only had a 16-fold increase (+/
- 5.8) within the same time period (Figure 5A). Similarly,
mBMSCs had a 402-fold increase (+/- 222.3) in cell
number while GFPTgBMSCs only had a 187-fold increase
(+/- 51.1) (Figure 5B).
Colony Forming Unit Assay
Assays for colony forming units offer a convenient means
of assessing the proliferative capacity that MSCs retain
after the cells have been expanded in culture [27,28]. The
proliferative capacity of mMSCs and GFPTgMSCs was
examined by comparing CFU assay results between these
groups of cells. No statistically significant differences were
found between mASCs (13.8 +/- 10.5), GFPTgASCs (17.2
+/- 8.9 CFUs), mBMSCs (22.0 +/- 6.7), or GFPTgBMSCs
(24.7 +/- 12.2) in their abilities to generate colony form-
ing units (Figure 6).
Discussion
Isolation of MSCs from mice is often more difficult than
from other species [29]. Only a small amount of bone
marrow and adipose tissue is available per mouse and
harvesting these tissues can sometimes be problematic.
Often there is unwanted growth of non-mesenchymal
cells that can take over the culture. However, these chal-
lenges can be overcome to develop murine mesenchymal
stem cell lines with consistently similar biologic proper-
ties. This study focused on comparing adipose derived
and bone marrow derived stem cells from eGFP transgenic
C57Bl/6 mice and normal C57Bl/6 mice. Even though
these cells were isolated from 3–4 donors for each cell
type, the characterizations of these four different cell types
are relatively comparable with few differences.
mMSCs from eGFP transgenic mice are similar in their
fibroblastic morphology and in differentiation capability
to those from non-transgenic mice. However, when
mASCs and GFPTgASCs are compared with mBMSCs and
GFPTgBMSCs there are clear distinctions. mASCs and
GFPTgASCs appear more flattened and wider in diameter
when compared to mBMSCs and GFPTgBMSCs. Both
types of mBMSCs undergo osteogenic differentiation
more readily than mASCs or GFPTgASCs. These distinc-
tions point to tissue-specific differences between murine
stem cells derived from adipose tissue and bone marrow.
Perhaps mASCs contain more adipogenic committed pro-
genitor cells compared with mBMSCs, and mBMSCs con-
tain more osteogenic committed progenitor cells
compared with mASCs. Finally, the expression of eGFP
does not seem to affect the ability to differentiate along
adipogenic or osteogenic lineages, and cells retain their
fluorescence even after undergoing differentiation.
All four cell types were also analyzed by flow cytometry
for specific cell surface markers. Cells were tested for
expression of markers such as CD106, Sca-1, CD34,
CD11b, and CD45. All cells exhibited very low expression
of epitopes generally associated with hematopoietic cells
such as CD34, CD11b, and CD45 [25]. These results sug-
gest that the cultures were virtually free of hematopoietic
cells. Approximately half of the cells expressed CD106,
which is a marker generally associated with mesenchymal
stem cells [25]. Most cells expressed Sca-1, which is a
marker associated with MSCs and also with hematopoi-
etic and endothelial progenitors [11,25,26]. The cell sur-
face marker profiles of these transgenic and non-
transgenic mASCs and mBMSCs are very similar to those
previously reported [9,24,30]. The presence of eGFP
appeared to have no effect on surface marker expression.
Interestingly, mMSCs derived from both bone marrowBMC Cell Biology 2009, 10:3 http://www.biomedcentral.com/1471-2121/10/3
Page 7 of 12
(page number not for citation purposes)
Immunophenotypic profile of mMSCs and GFPTgMSCs Figure 4
Immunophenotypic profile of mMSCs and GFPTgMSCs. A. Stem cells (P10 or lower) were incubated with antibodies 
for CD106, Sca-1, CD34, CD11b, or CD45 and assayed by FACS. Each antibody was tested individually and with isotype con-
trols. B. Representative plots are shown with percentages corresponding to the average profile of all cell types. Red plot lines: 
isotype control; green plot: stem cells.
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A. Growth Curves of mASCs and GFPTgASCs Figure 5
A. Growth Curves of mASCs and GFPTgASCs. Cells were plated at an original density of 100 cells/cm2 and cultured for 
12 days. The difference in growth rate between mASCs and GFPTgASCs is not statistically significant (p > 0.05). B. Growth 
Curves of mBMSCs and GFPTgBMSCs. Cells were plated at an original density of 100 cells/cm2 and cultured for 12 days. The 
difference in growth rate between mBMSCs and GFPTgBMSCs is not statistically significant (p > 0.05).
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and adipose tissue had similar cell surface marker profiles.
This is not surprising since both cell types are isolated
from the stromal cell fraction of the original tissue and are
isolated based on their adherence to plastic [9].
Comparisons of growth curves from the four cell types
yielded interesting results. First, the GFPTgMSCs seemed
to grow more slowly than their non-transgenic counter-
parts. However, the differences were not statistically sig-
nificant due to variation among donors. Perhaps
increasing the sample size of donors would decrease the
amount of variation and illustrate a significant difference
in growth kinetics. Secondly, it seems that adipose-
derived murine stem cells grow more slowly than those
derived from bone marrow. Again, the differences were
not statistically significant due to variation among
donors. Perhaps the media used to culture mASCs should
be customized to maximize growth potential.
Finally, all four cell types readily formed single-cell
derived colonies when plated at low density. The presence
of eGFP in the transgenic cells did not seem to affect the
proliferative capacity of the cells after expansion in cul-
ture.
Conclusion
The availability of mesenchymal stem cells with the
potential for the long-term stable expression of a genetic
marker has important applications for the advancement
of stem cell research. MSCs with a fluorescent marker can
be used in experiments utilizing transplantation proce-
dures since they can be easily tracked and identified. This
study highlights the importance of thorough in vitro char-
acterization of genetically marked cell populations before
in vivo transplantation. In summary, mASCs and mBMSCs
from non-transgenic and eGFP transgenic C57Bl/6 mice
have very similar characterization profiles. The presence
of eGFP in the transgenic cells does not seem to change
stem cell properties, thus supporting the notion that these
cells can be utilized in future experiments related to stem
cell therapy. These results may be interesting to investiga-
tors desiring to employ eGFP transgenic murine stem cell
lines in experiments related to stem cell therapeutics or
regenerative medicine.
Colony Forming Unit Assay Figure 6
Colony Forming Unit Assay. 100 cells were plated in a 56.7 cm2 culture dish and incubated for 14 days. Cells were stained 
with 3% Crystal Violet, and colonies 2 mm or larger were counted. The ability to form colonies was similar between all cell 
types (p > 0.05).
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Methods
Isolation of stem cells
Murine adipose derived stem cells and bone marrow
derived stem cells were obtained from C57Bl/6 mice
(Jackson Laboratories, Bar Harbor, ME). They were also
obtained from the inbred transgenic strain C57Bl/6-
Tg(UBC-GFP)30Scha/J that ubiquitously expresses
enhanced green fluorescent protein (Jackson Laborato-
ries). Cells were obtained from 3–4 donors of both sexes
from each strain. All donors were 2–4 months old and
were individually euthanized by CO2. All procedures per-
formed conform to the requirements of the Animal Wel-
fare Act and protocols approved by the Institutional
Animal Care and Use Committee at Tulane University. All
mice were maintained under standard housing conditions
in a pathogen-free environment with free access to food
and water.
mBMSCs and GFPTgBMSCs were obtained from two
femurs and two tibiae from each donor which were
removed and cleaned of connective tissue. The ends of
each tibia and femur were clipped off to expose the mar-
row. A syringe was inserted into the bone and complete
expansion media (CEM) was pushed through the bone to
collect the marrow. The marrow was re-suspended in CEM
using a pipet and then filtered through a 70 μm nylon
mesh filter to remove any particulates. The mixture was
then centrifuged at 400 × g for 10 minutes at 4°C, and the
pellet was re-suspended in 3 ml CEM. The cells were then
plated in an 8.8 cm2 culture plate and washed with media
twice over a period of 6 hours to remove hematopoietic
cells. CEM consists of Iscove's Modified Dulbecco's
Medium (IMDM, Invitrogen, Carlsbad, CA) supple-
mented with 9% fetal bovine serum (FBS; Atlanta Biolog-
icals, Atlanta, GA), 9% horse serum (HS; Hyclone
Laboratories, Logan UT), 100 U/ml penicillin (Invitro-
gen), 100 μg/ml streptomycin (Invitrogen), 0.25 μg/ml
amphotericin B (Invitrogen), and 12 μM L-glutamine
(Invitrogen).
Adherent cells were washed after 24 hours, and fresh CEM
was added every 3 to 4 days until cells reached approxi-
mately 80% confluency. The cells were then washed with
PBS and lifted by incubation with 0.5 ml 0.25% trypsin/1
mM ethylenediaminetetraacetic acid (EDTA; Invitrogen)
for 2–5 minutes at 37°C. The trypsin was neutralized in 5
ml CEM, and all the cells (passage 1) were replated into a
56.7-cm2 culture dish. The cells were either frozen in liq-
uid nitrogen or expanded further. For freezing, the cells
were re-suspended and frozen in 5% dimethylsulfoxide
(DMSO), 15% FBS, and15% HS in IMDM by placement
in a -20°C freezer for 1 hour, then a -80°C freezer for 1
hour, and finally stored in liquid nitrogen.
mASCs and GFPTgASCs were isolated from inguinal fat
pads. The tissue was washed extensively with PBS contain-
ing 200 U/ml penicillin (Invitrogen), 200 μg/ml strepto-
mycin (Invitrogen), and 0.50 μg/ml amphotericin B
(Invitrogen). The fat was minced with sterile scalpels in
0.075% Collagenase Type I and incubated with the colla-
genase for 1 hour. The collagenase was then neutralized
with CEM and the mixture was re-suspended with vigor-
ous pipetting. The tissue was then washed with PBS and
filtered through a 70 μm nylon mesh filter. The suspen-
sion was centrifuged at 400 × g for 4 minutes at 4°C, and
the pellet was re-suspended in 2 ml CEM. The cells were
then plated on a 20.8 cm2 culture dish, and the media was
replaced after 24 hours. Adherent mASCs were cultured in
the same manner as mBMSCs.
mMSC Differentiation
Cells were plated in 6-well plates at 1000 cells/well and
incubated in CEM for 3 days. For osteogenesis, the cul-
tures were then incubated in CEM supplemented with 20
mM glycerol phosphate, 50 ng/mL thyroxine, 1 nM dex-
amethasone, and 50 μM ascorbate 2-phosphate (all from
Sigma, St Louis, MO). The media was changed 2 times per
week for 2 weeks. The cells were fixed with 10% formalin
for 20 minutes at RT and stained with Alizarin Red, pH 4.1
(Sigma) for 20 minutes at RT.
For the quantitative osteogenesis assay, cells were plated
in 96-well plates at 100 cells/well and cultured as afore-
mentioned for 2 weeks. The cells were then stained with
Alizarin Red and de-stained with 10% cetylpyridinium
chloride for 30 minutes. The amount of Alizarin Red was
determined by measuring the optical density (OD) of the
solution at 560 nm. The results were then normalized to
the protein contents of the samples.
For adipogenesis, the cultures were incubated in CEM
supplemented with 5 μg/mL insulin, 50 μM indometh-
acin, 1 μM dexamethasone, and 0.5 μM 3-isobutyl-1-
methylxanthine (IBMX; all from Sigma). The medium was
changed 2 times per week for 2 weeks. The cells were fixed
with 10% formalin for 20 minutes at RT and stained with
0.5% Oil Red O (Sigma) in methanol (Sigma) for 20 min-
utes at RT.
For the quantitative adipogenesis assay, cells were plated
in 96-well plates at 100 cells/well and cultured as afore-
mentioned for 2 weeks. The cells were then stained with
Oil Red O and de-stained with isopropyl alchohol. The
amount of Oil Red O was determined by measuring the
OD of the solution at 520 nm. The results were then nor-
malized to the protein contents of the samples.
For chondrogenesis, a pellet culture system was used as
previously described [24]. Approximately 2 × 105 mMSCsBMC Cell Biology 2009, 10:3 http://www.biomedcentral.com/1471-2121/10/3
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(passage 8 or lower) were placed in a 15-mL polypropyl-
ene tube (Falcon, Bedford, MA), and pelleted by centrifu-
gation. The pellet was cultured at 37°C with 5% CO2 in
500 μL chondrogenic media that contained 500 ng/mL
bone morphogenic protein-6 (BMP-6; R&D Systems, Min-
neapolis, MN) in addition to high-glucose DMEM supple-
mented with 10 ng/mL transforming growth factor-3
(TGF-β3; R&D Systems), 10-7 M dexamethasone (Sigma),
50 μg/mL ascorbate-2-phosphate (Sigma), 40 μg/mL pro-
line (Sigma), 100 μg/mL pyruvate (Sigma), and 50 mg/
mL ITS+ Premix (Becton Dickinson, Bedford, MA; 6.25
μg/mL insulin, 6.25 μg/mL transferrin, 6.25 ng/mL selen-
ious acid, 1.25 mg/mL bovine serum albumin, and 5.35
mg/mL linoleic acid). The medium was replaced every 3
to 4 days for 21 days. For microscopy, the pellets were
embedded in paraffin, cut into 5 μm thick sections and
stained with Toluidine Blue Sodium Borate (Sigma).
FACS analysis
Cells (passage 9 or lower) were trypsinized, collected,
washed with PBS, and incubated for 1 hour at 4°C with
phycoerythrin (PE)-conjugated antibodies against Sca-1
(Beckton Dickinson [BD]), CD34 (eBiosciences), CD106
(vascular adhesion molecule-1 [VCAM-1]) (Abcam),
CD11b (BD), CD45 (BD), IgG2α (BD), IgG2β (BD), or
IgG1 (Chemicon). Excess antibody was removed by wash-
ing cells with PBS, and cells were fixed in 1% para-formal-
dehyde. Detection of PE labeling was performed on a
FACScalibur cytometer (BD, San Jose, USA), and results
were analyzed using FlowJo software.
Examination of Growth Rates
Cells (passage 9 or lower) were plated at 100 cells/cm2 in
a 56.7 cm2 culture dish in triplicate in CEM and cultured
for 12 days. The media was changed every 3 days, and cells
were trypsinized and pelleted every 3 days to analyze fold
increase in density with a hemacytometer.
Colony Forming Unit Assay
In order to perform a colony forming unit (CFU) assay,
cells (passage 9 or lower) were plated at a density of 100
cells in a 56.7 cm2 culture dish (1.76 cells/cm2). The cells
were cultured for 14 days with fresh media added after 7
days. The plates were then washed with PBS and stained
with 3% Crystal Violet at room temperature for 30 min-
utes. All colonies greater than 2 mm in diameter were
counted. The CFU assay was performed in triplicate for
each donor from three different frozen vials of cells.
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